Abramson J, Adler J, Dunger J, Evans R, Green T, Pritzel A, Ronneberger O, Willmore L, Ballard AJ, Bambrick J, Bodenstein SW, Evans DA, Hung CC, O’Neill M, Reiman D, Tunyasuvunakool K, Wu Z, Zemgulyte A, Arvaniti E, Beattie C, Bertolli O, Bridgland A, Cherepanov A, Congreve M, Cowen-Rivers AI, Cowie A, Figurnov M, Fuchs FB, Gladman H, Jain R, Khan YA, Low CMR, Perlin K, Potapenko A, Savy P, Singh S, Stecula A, Thillaisundaram A, Tong C, Yakneen S, Zhong ED, Zielinski M, Zidek A, Bapst V, Kohli P, Jaderberg M, Hassabis D, Jumper JM (2024) Accurate structure prediction of biomolecular interactions with AlphaFold 3. Nature 630(8016):493–500. https://doi.org/10.1038/s41586-024-07487-w

Article  CAS  PubMed  PubMed Central  Google Scholar 

Armstrong AE, Belzberg AJ, Crawford JR, Hirbe AC, Wang ZJ (2023) Treatment decisions and the use of MEK inhibitors for children with neurofibromatosis type 1-related plexiform neurofibromas. BMC Cancer 23(1):553. https://doi.org/10.1186/s12885-023-10996-y

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ashkenazy H, Abadi S, Martz E, Chay O, Mayrose I, Pupko T, Ben-Tal N (2016) ConSurf 2016: an improved methodology to estimate and visualize evolutionary conservation in macromolecules. Nucleic Acids Res 44(W1):W344-350. https://doi.org/10.1093/nar/gkw408

Article  CAS  PubMed  PubMed Central  Google Scholar 

Auf der Maur P, Trefny MP, Baumann Z, Vulin M, Correia AL, Diepenbruck M, Kramer N, Volkmann K, Preca BT, Ramos P, Leroy C, Eichlisberger T, Buczak K, Zilli F, Okamoto R, Rad R, Jensen MR, Fritsch C, Zippelius A, Stadler MB, Bentires-Alj M (2023) N-acetylcysteine overcomes NF1 loss-driven resistance to PI3Kα inhibition in breast cancer. Cell Rep Med 4(4):101002. https://doi.org/10.1016/j.xcrm.2023.101002

Article  CAS  PubMed  PubMed Central  Google Scholar 

Awad MM, Liu S, Rybkin II, Arbour KC, Dilly J, Zhu VW, Johnson ML, Heist RS, Patil T, Riely GJ, Jacobson JO, Yang X, Persky NS, Root DE, Lowder KE, Feng H, Zhang SS, Haigis KM, Hung YP, Sholl LM, Wolpin BM, Wiese J, Christiansen J, Lee J, Schrock AB, Lim LP, Garg K, Li M, Engstrom LD, Waters L, Lawson JD, Olson P, Lito P, Ou SI, Christensen JG, Jänne PA, Aguirre AJ (2021) Acquired resistance to KRAS(G12C) inhibition in cancer. N Engl J Med 384(25):2382–2393. https://doi.org/10.1056/NEJMoa2105281

Article  CAS  PubMed  PubMed Central  Google Scholar 

Balu K, Purohit R (2013) Mutational analysis of TYR gene and its structural consequences in OCA1A. Gene 513(1):184–195. https://doi.org/10.1016/j.gene.2012.09.128

Article  CAS  Google Scholar 

Bao C, Wang S, Jiang L, Fang Z, Zou K, Lin J, Chen S, Fang H (2023) OpenXGR: a web-server update for genomic summary data interpretation. Nucleic Acids Res 51(W1):W387-w396. https://doi.org/10.1093/nar/gkad357

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bendl J, Stourac J, Salanda O, Pavelka A, Wieben ED, Zendulka J, Brezovsky J, Damborsky J (2014) PredictSNP: robust and accurate consensus classifier for prediction of disease-related mutations. PLoS Comput Biol 10(1):e1003440. https://doi.org/10.1371/journal.pcbi.1003440

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bergoug M, Doudeau M, Godin F, Mosrin C, Vallée B, Bénédetti H (2020) Neurofibromin structure, functions and regulation. Cells 9(11):2365. https://doi.org/10.3390/cells9112365

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bhardwaj V, Singh R, Singh P, Purohit R, Kumar S (2020) Elimination of bitter-off taste of stevioside through structure modification and computational interventions. J Theor Biol 486:110094. https://doi.org/10.1016/j.jtbi.2019.110094

Article  CAS  PubMed  Google Scholar 

Carton C, Evans DG, Blanco I, Friedrich RE, Ferner RE, Farschtschi S, Salvador H, Azizi AA, Mautner V, Röhl C, Peltonen S, Stivaros S, Legius E, Oostenbrink R (2023) ERN GENTURIS tumour surveillance guidelines for individuals with neurofibromatosis type 1. EClinicalMedicine 56:101818. https://doi.org/10.1016/j.eclinm.2022.101818

Article  PubMed  PubMed Central  Google Scholar 

Chaker-Margot M, Werten S, Dunzendorfer-Matt T, Lechner S, Ruepp A, Scheffzek K, Maier T (2022) Structural basis of activation of the tumor suppressor protein neurofibromin. Mol Cell 82(7):1288-1296.e1285. https://doi.org/10.1016/j.molcel.2022.03.011

Article  CAS  PubMed  Google Scholar 

Chen CW, Lin MH, Liao CC, Chang HP, Chu YW (2020) iStable 2.0: Predicting protein thermal stability changes by integrating various characteristic modules. Comput Struct Biotechnol J 18:622–630. https://doi.org/10.1016/j.csbj.2020.02.021

Article  CAS  PubMed  PubMed Central  Google Scholar 

Coy S, Rashid R, Stemmer-Rachamimov A, Santagata S (2020) An update on the CNS manifestations of neurofibromatosis type 2. Acta Neuropathol 139(4):643–665. https://doi.org/10.1007/s00401-019-02029-5

Article  PubMed  Google Scholar 

Cui Y, Morrison H (2019) Construction of cloning-friendly minigenes for mammalian expression of full-length human NF1 isoforms. Hum Mutat 40(2):187–192. https://doi.org/10.1002/humu.23681

Article  CAS  PubMed  Google Scholar 

De Baets G, Van Durme J, Reumers J, Maurer-Stroh S, Vanhee P, Dopazo J, Schymkowitz J, Rousseau F (2012) SNPeffect 4.0: on-line prediction of molecular and structural effects of protein-coding variants. Nucleic Acids Res 40(Database issue):D935–D939. https://doi.org/10.1093/nar/gkr996

Article  CAS  PubMed  Google Scholar 

Ellegren H, Galtier N (2016) Determinants of genetic diversity. Nat Rev Genet 17(7):422–433. https://doi.org/10.1038/nrg.2016.58

Article  CAS  PubMed  Google Scholar 

Fortuno C, James PA, Young EL, Feng B, Olivier M, Pesaran T, Tavtigian SV, Spurdle AB (2018) Improved, ACMG-compliant, in silico prediction of pathogenicity for missense substitutions encoded by TP53 variants. Hum Mutat 39(8):1061–1069. https://doi.org/10.1002/humu.23553

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ge F, Zhang Y, Xu J, Muhammad A, Song J, Yu DJ (2022) Prediction of disease-associated nsSNPs by integrating multi-scale ResNet models with deep feature fusion. Brief Bioinform 23(1):bbab530. https://doi.org/10.1093/bib/bbab530

Article  CAS  PubMed  Google Scholar 

Giraud JS, Bièche I, Pasmant É, Tlemsani C (2023) NF1 alterations in cancers: therapeutic implications in precision medicine. Expert Opin Investig Drugs 32(10):941–957. https://doi.org/10.1080/13543784.2023.2263836

Article  CAS  PubMed  Google Scholar 

Gu L, Robinson RA (2016) A simple isotopic labeling method to study cysteine oxidation in Alzheimer’s disease: oxidized cysteine-selective dimethylation (OxcysDML). Anal Bioanal Chem 408(11):2993–3004. https://doi.org/10.1007/s00216-016-9307-4

Article  CAS  PubMed  Google Scholar 

Guiley KZ, Shokat KM (2023) A small molecule reacts with the p53 somatic mutant Y220C to rescue wild-type thermal stability. Cancer Discov 13(1):56–69. https://doi.org/10.1158/2159-8290.Cd-22-0381

Article  CAS  PubMed  Google Scholar 

Harder A (2021) MEK inhibitors - novel targeted therapies of neurofibromatosis associated benign and malignant lesions. Biomark Res 9(1):26. https://doi.org/10.1186/s40364-021-00281-0

Article  PubMed  PubMed Central  Google Scholar 

Kehrer-Sawatzki H, Cooper DN (2022) Challenges in the diagnosis of neurofibromatosis type 1 (NF1) in young children facilitated by means of revised diagnostic criteria including genetic testing for pathogenic NF1 gene variants. Hum Genet 141(2):177–191. https://doi.org/10.1007/s00439-021-02410-z

Article  PubMed  Google Scholar 

Kim YE, Hipp MS, Bracher A, Hayer-Hartl M, Hartl FU (2013) Molecular chaperone functions in protein folding and proteostasis. Annu Rev Biochem 82:323–355. https://doi.org/10.1146/annurev-biochem-060208-092442

Article  CAS  PubMed  Google Scholar 

Kresak JL, Walsh M (2016) Neurofibromatosis: a review of NF1, NF2, and schwannomatosis. J Pediatr Genet 5(2):98–104.